InvestorsHub Logo

TheDane

11/16/21 10:01 AM

#384599 RE: bradfordbros #384589

Assuming there’s someone willing to buy it, I say getter done! It used to be a sacrilege to suggest anything less than $20/share. Now?

$1.00 is looking pretty good about now. That’s possible with a Phase 3 B-OM or something along this line. If Leo can get BrilAcidin into more government labs then maybe it’s worth hanging on longer. Funding is the issue now.